Monalizumab, CAS [[1228763-95-8]]

Produktübersicht

• Artikelname: Monalizumab, CAS [[1228763-95-8]]
• Artikelnummer: MCE-HY-P99032
• Hersteller Artikelnummer: HY-P99032
• Alternativnummer: MCE-HY-P99032-25MG,MCE-HY-P99032-10MG,MCE-HY-P99032-1MG,MCE-HY-P99032-5MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: IPH2201

Produktbeschreibung

Monalizumab (IPH2201) is an immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-gamma production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC)[1][2].

Produkteigenschaften

• Molekulargewicht: (146.3 kDa)
• Reinheit: 99.93
• CAS Nummer: [1228763-95-8]
• Target-Kategorie: Checkpoint Kinase (Chk),IFNAR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies